• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Qualitative assessments of density and background parenchymal enhancement on contrast-enhanced spectral mammography associated with breast cancer risk in high-risk women.在高危女性中,对比增强光谱乳腺摄影术与乳腺癌风险相关的密度和背景实质增强的定性评估。
Br J Radiol. 2023 Aug;96(1148):20220051. doi: 10.1259/bjr.20220051. Epub 2023 May 25.
2
Background Parenchymal Enhancement at Contrast-Enhanced Spectral Mammography (CESM) as a Breast Cancer Risk Factor.背景:对比增强光谱乳腺摄影术(CESM)中的实质增强作为乳腺癌的一个风险因素。
Acad Radiol. 2020 Sep;27(9):1234-1240. doi: 10.1016/j.acra.2019.10.034. Epub 2019 Dec 4.
3
Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.对比增强光谱乳腺摄影(CESM)中的实质强化能否代表一种新的乳腺癌风险因素?与已知放射学风险因素的相关性。
Clin Radiol. 2017 Dec;72(12):1085.e1-1085.e9. doi: 10.1016/j.crad.2017.07.017. Epub 2017 Sep 1.
4
Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.基于人群的 MRI 背景实质增强与未来原发性乳腺癌风险的相关性评估。
J Clin Oncol. 2019 Apr 20;37(12):954-963. doi: 10.1200/JCO.18.00378. Epub 2019 Jan 9.
5
Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study.背景实质增强在对比增强光谱乳腺摄影中不代表乳腺癌的影响因素:一项初步研究。
Medicine (Baltimore). 2020 Dec 24;99(52):e23857. doi: 10.1097/MD.0000000000023857.
6
Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?磁共振成像中背景实质强化、纤维腺体量的定性评估以及乳腺X线密度与乳腺癌风险相关吗?
Radiology. 2015 Aug;276(2):371-80. doi: 10.1148/radiol.2015142304. Epub 2015 May 12.
7
Analysis of background parenchymal enhancement (BPE) on contrast enhanced spectral mammography compared with magnetic resonance imaging.对比增强光谱乳腺摄影术与磁共振成像相比对背景实质强化(BPE)的分析。
Ginekol Pol. 2021;92(2):92-97. doi: 10.5603/GP.a2020.0169. Epub 2021 Jan 15.
8
Background Parenchymal Enhancement in Contrast-enhanced Spectral Mammography: A Retrospective Analysis and a Pictorial Review of Clinical Cases.背景实质增强在对比增强光谱乳腺摄影中的应用:回顾性分析及临床病例的图像回顾。
In Vivo. 2022 Mar-Apr;36(2):853-858. doi: 10.21873/invivo.12773.
9
Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.与对比增强乳腺摄影中背景实质增强相关的因素。
AJR Am J Roentgenol. 2021 Feb;216(2):340-348. doi: 10.2214/AJR.19.22353. Epub 2020 Dec 23.
10
Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.对比增强光谱乳腺摄影与乳腺磁共振成像背景实质强化的比较。
Radiology. 2017 Jan;282(1):63-73. doi: 10.1148/radiol.2016160284. Epub 2016 Jul 4.

引用本文的文献

1
Factors Influencing Background Parenchymal Enhancement in Contrast-Enhanced Mammography Images.影响乳腺造影增强图像中背景实质强化的因素。
Diagnostics (Basel). 2024 Oct 8;14(19):2239. doi: 10.3390/diagnostics14192239.

本文引用的文献

1
Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI).欧洲乳腺影像学会(EUSOBI)关于致密型乳腺女性乳腺癌筛查的建议。
Eur Radiol. 2022 Jun;32(6):4036-4045. doi: 10.1007/s00330-022-08617-6. Epub 2022 Mar 8.
2
Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study.背景实质增强在对比增强光谱乳腺摄影中不代表乳腺癌的影响因素:一项初步研究。
Medicine (Baltimore). 2020 Dec 24;99(52):e23857. doi: 10.1097/MD.0000000000023857.
3
Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography: Influence of Age, Breast Density, Menstruation Status, and Menstrual Cycle Timing.背景:对比增强光谱乳腺摄影中的实质增强:年龄、乳腺密度、月经状态和月经周期时间的影响。
Sci Rep. 2020 May 25;10(1):8608. doi: 10.1038/s41598-020-65526-8.
4
Background Parenchymal Enhancement at Contrast-Enhanced Spectral Mammography (CESM) as a Breast Cancer Risk Factor.背景:对比增强光谱乳腺摄影术(CESM)中的实质增强作为乳腺癌的一个风险因素。
Acad Radiol. 2020 Sep;27(9):1234-1240. doi: 10.1016/j.acra.2019.10.034. Epub 2019 Dec 4.
5
Breast cancer statistics, 2019.乳腺癌统计数据,2019 年。
CA Cancer J Clin. 2019 Nov;69(6):438-451. doi: 10.3322/caac.21583. Epub 2019 Oct 2.
6
Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.基于人群的 MRI 背景实质增强与未来原发性乳腺癌风险的相关性评估。
J Clin Oncol. 2019 Apr 20;37(12):954-963. doi: 10.1200/JCO.18.00378. Epub 2019 Jan 9.
7
Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.对比增强光谱乳腺摄影(CESM)中的实质强化能否代表一种新的乳腺癌风险因素?与已知放射学风险因素的相关性。
Clin Radiol. 2017 Dec;72(12):1085.e1-1085.e9. doi: 10.1016/j.crad.2017.07.017. Epub 2017 Sep 1.
8
Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.对比增强光谱乳腺摄影与乳腺磁共振成像背景实质强化的比较。
Radiology. 2017 Jan;282(1):63-73. doi: 10.1148/radiol.2016160284. Epub 2016 Jul 4.
9
Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?磁共振成像中背景实质强化、纤维腺体量的定性评估以及乳腺X线密度与乳腺癌风险相关吗?
Radiology. 2015 Aug;276(2):371-80. doi: 10.1148/radiol.2015142304. Epub 2015 May 12.
10
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.

在高危女性中,对比增强光谱乳腺摄影术与乳腺癌风险相关的密度和背景实质增强的定性评估。

Qualitative assessments of density and background parenchymal enhancement on contrast-enhanced spectral mammography associated with breast cancer risk in high-risk women.

机构信息

Physical Examination Center, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China.

Department of Ultrasound, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China.

出版信息

Br J Radiol. 2023 Aug;96(1148):20220051. doi: 10.1259/bjr.20220051. Epub 2023 May 25.

DOI:10.1259/bjr.20220051
PMID:37227804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10392639/
Abstract

OBJECTIVE

To investigate the correlation between the risk of breast cancer for high-risk females and the density and background parenchymal enhancement (BPE) on contrast-enhanced spectral mammography (CESM).

METHODS

Females at high-risk, without breast cancer history and received CESM from July 2016 to December 2017 were retrospectively enrolled. The longest follow-up time was 4.5 years, and patients who developed breast cancer with maximized follow-up time were classified as cancer cohort, while females who did not develop breast cancer were categorized as control cohort. These two cohorts were one-to-one matched in age, family and/or genetic history of breast cancer, menopausal status and status. The density and BPE at CESM imaging were assessed. Conditional logistic regression was applied to evaluate the relationship between imaging features and breast cancer risk.

RESULTS

During the follow-up interval, 90 women at high-risk without history of breast cancer were newly diagnosed. Compared with minimal BPE, increasing BPE levels were associated with the risk of breast cancer among high-risk females in a time interval of 4.5 years (mild: odds ratio [OR]=3.2, = 0.001; moderate: OR = 4.0, = 0.002; marked: OR = 11.2, < 0.001). In addition, females with mild, moderate or marked BPE were four times more likely to be diagnosed with breast cancer than females with minimal BPE in a time interval of 4.5 years (OR = 4.0, < 0.001).

CONCLUSION

Qualitative CESM BPE assessment may be useful in the prediction of breast cancer risk among high-risk females.

ADVANCES IN KNOWLEDGE

• Qualitative CESM BPE assessment may be useful in the prediction of breast cancer risk among high-risk women during the follow-up period of 4.5 years. • The significance of breast density as an independent risk factor is not fully established for high-risk women during the follow-up period of 4.5 years.

摘要

目的

研究高危女性乳腺癌风险与对比增强光谱乳腺摄影(CESM)密度和背景实质增强(BPE)之间的相关性。

方法

回顾性纳入 2016 年 7 月至 2017 年 12 月期间接受 CESM 检查且无乳腺癌病史的高危女性。最长随访时间为 4.5 年,随访时间最长且发生乳腺癌的患者被归类为癌症队列,而未发生乳腺癌的女性被归类为对照组。这两个队列在年龄、家族和/或乳腺癌遗传史、绝经状态和状态方面按 1:1 匹配。评估 CESM 成像的密度和 BPE。应用条件逻辑回归评估成像特征与乳腺癌风险之间的关系。

结果

在随访期间,90 名无乳腺癌病史的高危女性被新诊断为乳腺癌。与最小 BPE 相比,在 4.5 年的时间间隔内,BPE 水平增加与高危女性乳腺癌风险相关(轻度:比值比[OR]=3.2, = 0.001;中度:OR = 4.0, = 0.002;显著:OR = 11.2, < 0.001)。此外,在 4.5 年的时间间隔内,BPE 轻度、中度或显著的女性比 BPE 最小的女性诊断出乳腺癌的可能性高 4 倍(OR = 4.0, < 0.001)。

结论

定性 CESM BPE 评估可能有助于预测高危女性的乳腺癌风险。

知识进展

•定性 CESM BPE 评估可能有助于预测高危女性在 4.5 年随访期间的乳腺癌风险。•在 4.5 年的随访期间,乳腺密度作为独立危险因素对高危女性的意义尚未完全确立。